Semnur Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | — | Sale | 11,945,151 | $16.00 | $191,122,416 | 181,804,849 | Sep 23, 2025 |
| Xu Jiandong | — | Purchase | 510,000 | $10.00 | $5,100,000 | 510,000 | Apr 11, 2022 |
| Denali Capital Global Investments LLC | — | Purchase | 510,000 | $10.00 | $5,100,000 | 510,000 | Apr 11, 2022 |